Black Rock Inc. Processa Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.44 - $0.73 $12,807 - $21,249	-29,109 Reduced 99.0%	293 $0
Q1 2023 May 12, 2023	BUY	$0.41 - $1.3 $386 - $1,224	942 Added 3.31%	29,402 $14,000
Q4 2022 Feb 13, 2023	BUY	$1.1 - $50.0 $690 - $31,400	628 Added 2.26%	28,460 $31,000
Q3 2022 Nov 14, 2022	SELL	$2.0 - $46.8 $1,570 - $36,738	-785 Reduced 2.74%	27,832 $63,000
Q2 2022 Aug 12, 2022	SELL	$1.68 - $3.55 $791 - $1,672	-471 Reduced 1.62%	28,617 $81,000
Q1 2022 May 12, 2022	SELL	$3.01 - $5.21 $4,253 - $7,361	-1,413 Reduced 4.63%	29,088 $87,000
Q4 2021 Feb 10, 2022	BUY	$4.03 - $8.42 $14,012 - $29,276	3,477 Added 12.87%	30,501 $149,000
Q3 2021 Nov 09, 2021	SELL	$5.28 - $8.61 $3,020 - $4,924	-572 Reduced 2.07%	27,024 $232,000
Q2 2021 Aug 11, 2021	BUY	$6.15 - $10.95 $169,715 - $302,176	27,596 New	27,596 $226,000

Ticker PCSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,856,200
Market Cap $18.4M
Description
Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosi...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.